USA – Stakeholders seek flexibility, greater harmonization in FDA human subject protection rules

Commenters from the pharmaceutical and medical device industries, academia and medical groups urged the US Food and Drug Administration (FDA) to help ease the...

USA – FDA authorizes marketing of first diagnostic test for detecting Zika virus antibodies

Today, the U.S. Food and Drug Administration authorized marketing of a diagnostic test to detect Zika virus immunoglobulin (IgM) antibodies in human blood. The ZIKV Detect...

USA – FDA proposes breakthrough status for devices that address health disparities

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) has proposed that devices that aim to eliminate disparities in...
FDA Warns of Cybersecurity Vulnerabilities in Pacemakers, Blood Glucose Monitors

USA – FDA recognizes three new international medical device software security standards

The US Food and Drug Administration (FDA) has recognized three new standards related to software security on medical devices. The standards address taking a...
Coronavirus delays many FDA foreign inspections

USA – Industry seeks clarity, ICH Q9 alignment in FDA’s device production software...

Comments in response to the US Food and Drug Administration (FDA)’s draft guidance on software assurance for computer and data processing systems associated with...

USA – FDA publishes new dataset to aid medical device biocompatibility testing

The US Food and Drug Administration (FDA) has published a chemical dataset that analytical laboratories can use to demonstrate they can detect chemicals that...
Topical Drug Products for Cutaneous Application: Human Safety Assessment Guidance

USA – FDA issues roadmap to medical device regulatory guidance topics list for 2023

The US Food and Drug Administration has released a list of guidance documents it plans to issue over its 2023 fiscal year. FDA’s Center...

USA – FDA guidance proposes devices be deemed adulterated for refusing inspections

The US Food and Drug Administration’s (FDA) has issued draft guidance proposing that devices be deemed adulterated and refused entry to the US market...
Cybersécurité : un sujet à prendre au sérieux pour les dispositifs médicaux

USA – FDA proposes updates to device cybersecurity guidance

The US Food and Drug Administration (FDA) has released a draft guidance that proposes updating the agency’s final guidance on cybersecurity of medical devices. The update...

USA – MedCon: Consider the device risk management file a ‘living document’

Device manufacturers need to keep their risk documentation up to date throughout the total product life cycle by monitoring production and post-production information, according...

NOS PROCHAINES FORMATIONS